Cognitive dysfunctions such as mild cognitive impairment (MCI), Alzheimer's disease (AD),
and other forms of dementia are recognized as common comorbidities of type 2 diabetes …

Neurological disorders such as stroke, multiple sclerosis, as well as the neurodegenerative
diseases Parkinson's or Alzheimer's disease are accompanied or even powered by danger …

Aging is a key risk factor for chronic diseases of the elderly. MicroRNAs regulate post-
transcriptional gene silencing through base-pair binding on their target mRNAs. We …

While some individuals age without pathological memory impairments, others develop age‐
associated cognitive diseases. Since changes in cognitive function develop slowly over time …

Alzheimer's disease (AD) is a common neurodegenerative disease in the elderly and is the
most common type of dementia. AD is mostly gradual onset, and involves slow, progressive …

This paper was aimed to analyze the microRNA (miRNA) signatures in Alzheimer disease
(AD) and find the significant expressions of miRNAs, their target genes, the functional …

Abstract Background MicroRNA-146a-5p (miR-146a-5p) is a key regulator of inflammatory
processes. Expression of miR-146a-5p is altered in target organs of diabetic complications …

Alzheimer's disease (AD), the most prevalent neurodegenerative disease in the growing
population of elderly people, is still lacking minimally-invasive circulating biomarkers that …

Muscular aging is a complex process and underlying physiological mechanisms are not fully
clear. In recent years, the participation of the NF-kB pathway and the NLRP3 inflammasome …

The neurological damage of Alzheimer's disease (AD) is thought to be irreversible upon
onset of dementia-like symptoms, as it takes years to decades for occult pathologic changes …